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Abstract
International comparisons of horizontal inequity in health have recently become one of
the most pertinent issues in health economics. Japan has not been included in these
international comparisons. This omission is rectified in this paper, which focuses on Japan.
Moreover, we consider its dynamics over six years from 1992 to 1998. The dynamics has
never considered in this fields. In a rigorous international comparison, we cannot find any
horizontal inequity in health in Japan and almost similar to Belgium.
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1 Introduction
Inequity in health has recently become one of the most pertinent and relevant issues in
health economics and health policy. Much research on methodology and on international
comparisons has been carried out by Wagstaff, Doorslaer and Paci (1989), Wagstaff, Paci
and Doorslaer (1991), Doorslaer and Wagstaff (1992), Wagstaff and Doorslaer (1993),
Wagstaff and Doorslaer (1994), Doorslaer, Wagstaff et al. (1997, 2000), and Kakwani,
Wagstaff and Doorslaer (1997). In particular, research on horizontal inequity has been
done by Doorslaer, Wagstaff et al. (2000), and most recently, by Wagstaff and Doorslaer
(2000).
Eleven OECD countries were studied on the basis of reasonably comparable definitions.
Unfortunately, Japan has been excluded in all previous studies. This paper adds Japan to
the current list of countries studied. It adopts the same or comparable definitions of social
and economic conditions, health, and estimation methods as other studies. In addition, this
paper provides some evidence on the dynamics of inequity, which has not been investigated
fully in other studies.
Before considering the measurement of health, the institutional background in Japan is
summarized. In 1961, Japan completed compulsory public health insurance and coverage
for all residents. In 1998 (which our paper covers), a new law was introduced, requiring
co-insurance rates of 20% for the employed, and 30% for others, such as the self-employed
and dependents. For people over 70 years of age, the co-payment rate is 10%, and is limited
to approximately 4000 yen (about US$36 in 2001 prices) per month. However, big firms
sometimes subsidize their employees by reducing their co-payments to less than the legal
requirement. If very poor people cannot pay the premiums, medical services are provided
as welfare. Thus, everybody can enjoy accessing to medical services in Japan, even though
there may be exceptional cases.
The public health insurance system provides reimbursement on a fee-for-service (FFS)
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basis. Although the government controls the price of treatment and drugs almost every
year, it cannot directly control the choice of treatment and/or drugs, unlike the Utilization
Review at HMO. The insurer cannot control the budget ex ante like NHS and sickness
benefits.
There is no regulation of the medical services chosen by patients, as in the gatekeeper in
NHS or difference coverage in HMO. The co-insurance rate is the same for services provided
in hospitals or clinics (either public or private), but congestion may implicitly impose an
opportunity cost. Of course, the number of beds is strictly regulated, but provision of
outpatient services are virtually unregulated.
Although private insurance exists it plays only a minor role, because public insurance
has such a comprehensive coverage of medical services. Shigeno (2000) shows that private
insurance appears to complement public insurance only through its income effect. Hence,
private insurance in Japan is very different from that in the USA and in European coun-
tries, and this is why it is usually excluded in health economics research of international
comparisons.
2 Data
The Comprehensive Survey of Living Standards in Japan (CSLSJ) has been conducted
every three years since 1986. The purpose of this survey is to investigate health, medical
services, pensions, welfare, incomes, and other factors affecting living standards. Ques-
tionnaires consist of four parts: family, individual, income, and savings. The number of
subjects, sampled randomly, in the family and individual parts are approximately 780,000
individuals (280,000 families), and the number for the income and savings surveys is ap-
proximately 120,000 individuals (40,000 families). The data used in this study are for 1992,
1995, and 1998.
Symptoms and diseases are surveyed in great detail, though there are minor differences
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among years. For example, in 1998, symptoms are listed as fever, fatigue, sleeplessness,
irritation, failing memory, headache, dizziness, bleary eyes, difficulty in seeing, tinnitus, dif-
ficulty in hearing, palpitation, difficulty in breathing, chest pain, coughs and sputum expec-
toration, the sniffles, noisy breathing, retching, diarrhoea, constipation, appetite loss, stom-
ach ache, haemorrhoids, toothache, dental problems, difficulty in chewing, rash, itching,
stiff shoulder, back pain, arthralgia, impairments of hands and feet, numbness, frigid hands
and feet, foot oedema, dysuria, frequent urination, incontinence, paramecia/merorrhalgia,
broken bones and sprains, wounds, and other symptoms. Respondents indicate the symp-
toms they have, but the survey does not collect information about whether respondents
have considered seeing a doctor, or information concerning the seriousness of the symptoms.
The wording of CSLSJ for outpatient utilization is ”Do you currently go to visit to
phisician (general practitioner)?” Respondents indicate the diseases which apply to them
and which they concern the most, and their duration. However, it does not provide any
information about the number or frequency of visit to the doctor, or medical expenditure.
Note that the CSLSJ asks about the current situation with regard to symptoms and dis-
eases, whereas surveys in other countries define duration explicitly, and do not necessarily
ask about the current situation. Hence, we know only whether they suffered from some
symptoms or visit a doctor due to some diseases, and we do not know how long and how
sever it is except for the longest consulting in the disease. This undefined reference period
may be the most important difference from the survey in the other countries and we have
to remind it to understand the below analyses. Moreover, symptoms and diseases in the
CSLSJ include those other than chronic and/or severe illnesses, whereas other countries
limit questions to chronic or severe illnesses that disrupt daily activity.
Subjective health evaluation responses range from excellent to good, fair, poor, and very
poor. However, there is a problem with this question. Unlike in many countries, such as the
USA and the UK, respondents in Japan are not asked to evaluate their health in relation
to people of a similar age. This difference may affect the results and may introduce some
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inconsistency in the international comparisons. In fact, Honda and Ohkusa (2001) found
that, on the basis of this question, subjective health evaluation in Japan is very different
from that in the USA and the UK. Such discrepancies are unavoidable in international
comparisons. Therefore, comparisons should be interpreted carefully.
The sample used in the following analysis are limited for the age of 16 or older, but the
original surveys cover persons over six years of age, and those who are not hospitalized or
in residential care. This should be mentioned for international comparisons.
With income, as in the Dutch and U.S. survey, the survey provides the exact amount of
their household’s income as well as details of income sources.
3 The Measurement of Horizontal Inequity
In measuring horizontal inequity, three aspects need to be clarified, i.e. definition of demand
for medical care; definition of needs; and estimation methods. Definitions and estimation
methods used in this paper are as follows. Social and economic groups (SEG) are defined
by household disposable income per equivalent adult as in previous studies.
3.1 Definition of Demand for Medical Care
Several definitions of demand for medical care are employed in existing studies: for in-
stance, medical expenditure (Doorslaer, Wagstaff et al., 2000), visits to a doctor (Doorslaer,
Wagstaff et al., 2000, or Doorslaer, Koolman and Puffer,2001 ), and hospitalizations
(Doorslaer, Wagstaff et al., 2000). While medical expenditure and hospitalizations are
not available from CSLSJ, visits to a doctor can be used as a measure of demand for
medical care.
3.2 Definition of Needs
Concerning the definition of needs, existing studies use incidences of chronic illness (Doorslaer
and Wagstaff(1992)), and self-assessment of health (Doorslaer, Wagstaff et al.(1997)). Con-
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versely, Doorslaer, Wagstaff et al.(2000) define the needs as the estimated demand for med-
ical care which is explained by self-assessment of health (SAH) and/or chronic illness in
addition to demographic characteristics such as age and gender. Although CSLSJ does
not isolate chronic illness, it does survey symptoms as already explained. Moreover, it
also provides information on self-assessment of health. Hence we define the needs as the
estimated demand for outpatient services of the ith rank in income person Di whether
they go to visit the physicians. The employed explanatory variable are age Ai, gender Gi,
self-assessment of health Hi and/or symptoms Si. Thus the estimated equations in the full
version is
D∗i = α0 +
98X
j
αjAA
j
i +
98X
j
αAGjAjiGi + αGGi +
4X
l
αlHH li +
42X
m
αmS Smi + εi
Di =
(
1 if D∗i > 0
0 otherwise
(1)
where the superscript indicates the dummy variables. Age dummy represents from 15 to
98 years old by each age. Since self-assessment of health is classified by 5 categories, there
are four dummies for it. Dummies for symptoms are defined separately for each symptom.
Note that diseases are not used as explanatory variables because these are reported in the
CSLSJ for those who visit a doctor and thus their Di should be always one. In that case,
it is perfect prediction and thus these explanatory variables cannot be identified.
Alternatively, we modified the above equation as using the number of symptoms suf-
fered from instead of symptom dummies, and/or broader categorized in age as Doorslaer,
Wagstaff et al.(2000),i.e. 15-24, 25-44,45-64,65-74 and 75-1).
The estimation procedure is heteroscedasticity consistent probit. The predicted proba-
bility Φ(Dˆi) is the needs n in the following procedures.
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3.3 Estimation Method
First, the Concentration Index for medical care or needs should be defined following Kak-
wani, Wagstaff and Doorslaer (1997) as
2
µ+i
µ+σR
= α0 + α1Rt (2)
where the subscript i indicates the individual of the ith SEG, which means ith smallest
amount of income adjusted for household structure, and µ+i is the demand for medical care.
Adjustment for demographic characteristics for µ+i and µ
+ is made by using the average
health condition that applies to the people of the same age (9 categories spanning 10 years),
gender, and other demographic characteristics as the ith person.
µ+ is the average of µ+i over persons, Ri is the cumulative proportion up to the ith person
in order of income adjusted for household structure, and σR is its variance. The estimated
α1 is the Concentration Index of the demand for medical care. Similarly, the Concentration
Index of needs is defined by replacing µ by n, which is a measure of needs.
Following Wagstaff and Doorslaer(2000), its variance is adjusted for
V ar(Concentration Index) =
1
10
{
10X
t=1
fia
2
i − (1 + Concentration Index)2} (3)
at =
µ+i
µ+
(2Ri−1 − Concentration Index) + 2− qi−1 − qi (4)
qi =
1
µ+
iX
s=1
µ+s fs
The horizontal inequity measure is obtained by using the following estimation method.
2σ2R
"
µ+i
µ+
− n
+
i
n+
#
= β0 + β1Ri (5)
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V ar(Horizontal Inequity) =
1
N
(
1
N
NX
i=1
(aµi − ani )2 − Horizontal Inequity2
)
(6)
aµi =
µ+i
µ+
(2Ri − 1− Concentration Index forµ) + 2− qµt−1 − qµi
qi =
1
µ+
tX
s=1
µ+s fs
ani =
n+i
n+
(2Ri − 1− Concentration Index forn) + 2− qnt−1 − qni
qi =
1
n+
tX
s=1
n+s fs
The estimated coefficient of β1 is interpreted as horizontal inequity (Wagstaff, Doorslaer
et al.(2000), Doorslaer, Wagstaff et al.(2000)).
4 Empirical Results
Summary statistics are shown in Table 1. Almost 30% of individuals suffered some symp-
toms or were outpatients. The per capita income adjusted for the number of adults in the
household is about 3.2-3.7 million-yen (about US$2,700-3,000) per year, and this increases
a little over the six years. Even the smallest sample year has more than 70,000 samples.
Table 2’s show the estimation results for ”Needs” in several specifications. Each table
has ten specifications, i.e. age (classes or dummies) or health condition (using SAH, using
information of symptoms (list of dummies or the number of symptoms) , or using both as
explanatory variables, for three years. Namely, the upper panels show the results in the
case of age classes and the lower panels show the case of age dummies. The first to third
column in both panels indicate the results of SAH only, dummies for symptoms only, and
both of them, respectively. The results in the case of using the number of symptoms instead
of symptom dummies are summarized in the fourth and fifth columns. Note that these
numbers are the estimated coefficients and not the marginal effects, and thus it cannot be
interpreted directly. Obviously, almost all explanatory variables are significant and Wald
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statistics show they fit very well. Moreover, pseudo R2’s are very high despite of large
sample.
Table 3 indicates the distribution of outpatient utilization in the actual and the predicted
”Needs” in the many specifications in Table 2’s. These numbers imply that there are not
substantial differences in the pattern of the outpatient utilization over six years. Namely,
the utilization rate is the highest in the top income group and the lowest in the middle
income group. On the other hand, the distribution of the estimated ”Needs” with age
classes does not fit well and shows the positive relationship with income monotonically.
Conversely, if we use the age dummies instead of age classes, it fits very well. In other words,
differences in age is much more informative than the adopted classes for their ”Needs.”
The horizontal inequity measures are displayed in Figures 1, 2, and 3 for the three years
in the case of Needs defined by the first three columns in the upper panel in the three
Table 2’s. The solid line is horizontal inequity defined only by SAH, the dotted line is
horizontal inequity defined only by dummies of symptoms, and the dashed line indicates
the horizontal inequity defined by the both in eq. (1). Three figures exhibit the same
pattern. Namely, the solid lines deviate at most by 1% at 0.6-0.7 income classes and tend
to be pro-poor, which means over the 0% line. The dotted lines do not deviate by 0.2%
and show the particular pattern. These two types of lines are calculated by using SAH.
Conversely, the broken lines, which do not adjusted for SAH, indicate heavily pro-rich
inequity. It reaches about 6% at maximum in the 0.3-0.4 income classes. This suggests
Needs definition without SAH does not seems to be reliable.
While figures provide much information about horizontal inequity, the empirical results
should confirm and test it. Table 4 summarizes the empirical results of β1 in eq. (3), and
Table 5 summarizes horizontal inequity adjusted for regions. As figures indicate, there are
significant pro-rich in the case of using age classes and without SAH. These are significant
pro-rich inequity by 0.08 to 0.12. However, these inequities disappear by using SAH or age
dummies. All other cases without such exceptional cases imply that the null hypothesis
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of no inequity cannot be rejected. The most similar estimators with Doorslaer, Wagstaff
et al.(2000) and Doorslaer, Koolman and Puffer(2001) are -0.0006, .0019 and -0.0009 in
1992, 1995 and 1998, respectively. Hereafter, these three figures would be thought of as
the estimators of horizontal inequity in Japan.
Even though we controlled regions in eq.(3), there are no substantial change in the
numbers. Namely, there are significant pro-rich in the case of using age classes and without
SAH, and the similar figures for the previous studies are -0.0007, .0017 and -0.0005 for three
years.
We can summarize our findings as follows: First of all, the null hypothesis of no inequity
cannot be rejected. Secondly, there is not significant change in inequity over six years
and no clear trend. Thirdly, the estimated horizontal inequity is heavily affected by the
definition of ”Needs.” Especially, the omitting SAH contaminates the results heavily. It
casts the difficulty of international comparison. Finally, regional adjustment in eq.(3) dose
not affect the estimated inequity.
5 Concluding Remarks
Our findings are very straightforward. The null hypothesis of no inequity cannot be rejected
and Japan would have enjoyed one of the greatest equity in health among OECD countries.
In fact, these point estimator are larger than Spain(-0.0137), Ireland(-0.0098) and Italy(-
0.0098) , less than Austria(0.0389), Portugal(0.0524), UK(0.0074), Canada(0.0072) and
USA(0.0532)2). It is almost the same as Belgium(-0.0001). Comparison with Belgium, the
pro-rich inequity in Japan is larger than Belgium in 1995, but less in 1992 and 1998. The
null hypothesis that horizontal inequity in Japan is different form Belgium is not rejected
in the most detailed specifications.
However, we have to remind that the demand for outpatient services is defined whether
they visit to physicians currently, but in the previous OECD studies, it is defined by
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the number of visits to physicians (general practitioners) in a certain period (typically,
one year). In other words, CSLSJ does not provide any information about the number
of visits in a certain period in the past. It seems to be obvious to reduce the effects of
income inequality for health care utilization and thus it makes inequity measures very
small. Therefore, complete comparison with other OECD countries is remained for future
research.
Since there is not other comparable Japanese data to other OECD countries, we will have
to conduct a survey originally to obtain completely comparable data, for more rigorous
comparison.
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Footnotes
1) Doorslaer, Wagstaff et al.(2000) and Doorslaer, Koolman and Puffer(2001) are cor-
respondence to the case of broader age categories and symptoms dummies precisely.
2) These numbers in other OECD countries are cited from Doorslaer, Koolman and
Puffer(2001) in the case of all physician visit as utilizatin and with region information.
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Table 1: Summary Statistics
Year 1998 1995 1992
Average StandardAverage StandardAverage Standard
Deviation Deviation Deviation
Utilization 0.3156 0.4648 0.3271 0.4692 0.2996 0.4581
Adjusted Income 360.0 263.6 358.9 266.9 326.9 256.8
SAH
Excellent 0.2527 0.1888 0.3127 0.2149 0.3374 0.2236
Good 0.1746 0.1441 0.1760 0.1450 0.1608 0.1349
Fair 0.4500 0.2475 0.4091 0.2417 0.3956 0.2391
Poor 0.1115 0.0991 0.0930 0.0844 0.0958 0.0866
Very Poor 0.0111 0.0110 0.0092 0.0091 0.0104 0.0103
female 0.5231 0.4995 0.5222 0.4995 0.5255 0.4994
No. of symptoms 1.3160 2.7617 0.9909 2.1125 0.8988 2.0748
35-44 0.1515 0.3586 0.0627 0.2425 0.0648 0.2462
45-64 0.3547 0.4784 0.3885 0.4874 0.3685 0.4824
65-74 0.1277 0.3337 0.1340 0.3407 0.1303 0.3366
75- 0.0737 0.2614 0.1185 0.3232 0.1330 0.3396
No. of Samples 71999 85526 99518
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Table 2-1: The Estimation Result for Need in 1998
Age Classes
No. of Symptoms .101∗∗∗ .150∗∗∗
SAH
Good .458∗∗∗ .291∗∗∗ .396∗∗∗
Fair .593∗∗∗ .367∗∗∗ .495∗∗∗
Poor 1.40∗∗∗ .811∗∗∗ 1.02∗∗∗
Very Poor 1.78∗∗∗ 1.10∗∗∗ 1.23∗∗∗
Age Class
35-44 .250∗∗∗ .283∗∗∗ .263∗∗∗ .239∗∗∗ .268∗∗∗
45-64 .718∗∗∗ .714∗∗∗ .695∗∗∗ .683∗∗∗ .712∗∗∗
65-74 1.32∗∗∗ 1.25∗∗∗ 1.23∗∗∗ 1.25∗∗∗ 1.28∗∗∗
75- 1.50∗∗∗ 1.40∗∗∗ 1.37∗∗∗ 1.40∗∗∗ 1.46∗∗∗
Female .177∗∗∗ .159∗∗∗ .161∗∗∗ .141∗∗∗ .143∗∗∗
Female · Age Class
35-44 -.182∗∗∗ -.202∗∗∗ -.206∗∗∗ -.183∗∗∗ -.178∗∗∗
45-64 -.087∗∗∗ -.101∗∗∗ -.103∗∗∗ -.087∗∗∗ -.087∗∗∗
65-74 -.077∗∗∗ -.055∗∗∗ -.075∗∗∗ -.058∗∗∗ -.036∗∗∗
75- -.103∗∗∗ -.044∗∗ -.078∗∗∗ -.067∗∗∗ -.034∗
Constant -1.72∗∗∗ -1.56∗∗∗ -1.80∗∗∗ -1.70∗∗∗ -1.35∗∗∗
Symptom Dummies No Yes Yes No No
Wald statistics 524202 207300 4135.15 101900 181816
p-value ≤0.001 ≤0.001 ≤0.001 ≤0.001 ≤0.001
Log-likelihood -35802 -33753 -32997 -34801 -36053
Pseudo R2 0.1993 0.2451 0.2620 0.2217 0.1937
Age Dummies
No. of Symptoms .148∗∗∗ .099∗∗∗
SAH
Good .456∗∗∗ .291∗∗∗ .395∗∗∗
Fair .589∗∗∗ .365∗∗∗ .492∗∗∗
Poor 1.40∗∗∗ .814∗∗∗ 1.02∗∗∗
Very Poor 1.77∗∗∗ 1.10∗∗∗ 1.22∗∗∗
Female -5.97∗∗∗ 1.73∗∗∗ -5.52∗∗∗ 1.38∗∗∗ 1.27∗∗∗
Constant -1.67∗∗∗ -1.55∗∗∗ -1.75∗∗∗ -1.33∗∗∗ -1.64∗∗∗
Symptom Dummies No Yes Yes No No
Wald statistics 18500 70531 90521 7849.9 23021
p-value ≤0.001 ≤0.001 ≤0.001 ≤0.001 ≤0.001
Log-likelihood -35268 -33310 -32563 -35560 -34324
Pseudo R2 0.2113 0.2551 0.2718 0.2047 0.2324
Note: These number are estimated coefficients and not marginal effects.
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Table 2-2: The Estimation Result for Need in 1995
No. of Symptoms .127∗∗∗ .186∗∗∗
SAH
Good .459∗∗∗ .299∗∗∗ .396∗∗∗
Fair .566∗∗∗ .351∗∗∗ .464∗∗∗
Poor 1.39∗∗∗ .812∗∗∗ .999∗∗∗
Very Poor 1.82∗∗∗ 1.18∗∗∗ 1.32∗∗∗
Age Class
35-44 .130∗∗∗ .169∗∗∗ .134∗∗∗ .127∗∗∗ .176∗∗∗
45-64 .562∗∗∗ .618∗∗∗ .574∗∗∗ .547∗∗∗ .603∗∗∗
65-74 1.12∗∗∗ 1.12∗∗∗ 1.07∗∗∗ 1.09∗∗∗ 1.16∗∗∗
75- 1.38∗∗∗ 1.36∗∗∗ 1.29∗∗∗ 1.33∗∗∗ 1.43∗∗∗
Female .205∗∗∗ .183∗∗∗ .182∗∗∗ .178∗∗∗ .179∗∗∗
Female · Age Class
35-44 -.044 -.039 -.038 -.048 -.055
45-64 -.124∗∗∗ -.150∗∗∗ -.154∗∗∗ -.132∗∗∗ -.124∗∗∗
65-74 -.147∗∗∗ -.135∗∗∗ -.151∗∗∗ -.139∗∗∗ -.118∗∗∗
75- -.136∗∗∗ -.097∗∗∗ -.117∗∗∗ -.114∗∗∗ -.088∗∗
Constant -1.59∗∗∗ -1.50∗∗∗ -1.69∗∗∗ -1.60∗∗∗ -1.32∗∗∗
Symptom Dummies No Yes Yes No No
Wald statistics 15632 19816 20328 15542 12743
p-value ≤0.001 ≤0.001 ≤0.001 ≤0.001 ≤0.001
Log-likelihood -42829 -40246 -39366 -41708 -43138
Pseudo R2 0.1805 0.2300 0.2468 0.2020 0.1746
Age Dummies
No. of Symptoms .183∗∗∗ .124∗∗∗
SAH
Good .458∗∗∗ .301∗∗∗ .396∗∗∗
Fair .563∗∗∗ .352∗∗∗ .464∗∗∗
Poor 1.39∗∗∗ .817∗∗∗ 1.00∗∗∗
Very Poor 1.81∗∗∗ 1.18∗∗∗ 1.31∗∗∗
Female .982∗∗ .975 1.08 .856 .998
Constant -1.28∗∗∗ -1.24∗∗∗ -1.39∗∗∗ -1.04∗∗∗ -1.28∗∗∗
Symptom Dummies No Yes Yes No No
Wald statistics 16565 20549 21059 13825 16493
p-value ≤0.001 ≤0.001 ≤0.001 ≤0.001 ≤0.001
Log-likelihood -42220 -39746 -38871 -42572 -41116
Pseudo R2 0.1922 0.2395 0.2563 0.1854 0.2125
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Table 2-3: The Estimation Result for Need with Age Classes in 1992
No. of Symptoms .135∗∗∗ .203∗∗∗
SAH
Good .496∗∗∗ .331∗∗∗ .434∗∗∗
Fair .635∗∗∗ .403∗∗∗ .532∗∗∗
Poor 1.46∗∗∗ .810∗∗∗ 1.04∗∗∗
Very Poor 1.77∗∗∗ 1.02∗∗∗ 1.20∗∗∗
Age Class
35-44 -.036 .033 -.024 -.042∗ .033
45-64 .357∗∗∗ .432∗∗∗ .364∗∗∗ .342∗∗∗ .430∗∗∗
65-74 .880∗∗∗ .943∗∗∗ .866∗∗∗ .856∗∗∗ .963∗∗∗
75- 1.20∗∗∗ 1.24∗∗∗ 1.15∗∗∗ 1.16∗∗∗ 1.30∗∗∗
Female .123∗∗∗ .127∗∗∗ .119∗∗∗ .104∗∗∗ .109∗∗∗
Female · Age Class
35-44 .106∗∗∗ .077∗∗ .084∗∗ .095∗∗∗ .087∗∗∗
45-64 -.026 -.058∗∗ -.060∗∗ -.047∗ -.043∗
65-74 -.071∗∗ -.091∗∗∗ -.096∗∗∗ -.074∗∗ -.063∗∗
75- -.085∗∗∗ -.090∗∗∗ -.099∗∗∗ -.076∗∗ -.057∗
Constant -1.56∗∗∗ -1.46∗∗∗ -1.65∗∗∗ -1.56∗∗∗ -1.28∗∗∗
Symptom Dummies No Yes Yes No No
Wald statistics 17904 23357 23975 17746 13875
p-value ≤0.001 ≤0.001 ≤0.001 ≤0.001 ≤0.001
Log-likelihood -48550 -45452 -44421 -47221 -49081
Pseudo R2 0.1818 0.2341 0.2514 0.2042 0.1729
Age Dummies
No. of Symptoms .201∗∗∗ .133∗∗∗
SAH
Good .499∗∗∗ .334∗∗∗ .438∗∗∗
Fair .637∗∗∗ .407∗∗∗ .536∗∗∗
Poor 1.46∗∗∗ .820∗∗∗ 1.05∗∗∗
Very Poor 1.76∗∗∗ 1.02∗∗∗ 1.19∗∗∗
Female .193 .195 -.601 -.384∗∗∗ -.419
Constant -1.23∗∗∗ -1.20∗∗∗ -1.34∗∗∗ -1.01∗∗∗ -1.24∗∗∗
Symptom Dummies No Yes Yes No No
Wald statistics 18855 24087 24681 15192 18781
p-value ≤0.001 ≤0.001 ≤0.001 ≤0.001 ≤0.001
Log-likelihood -47867 -44889 -43858 -48434 -46588
Pseudo R2 0.1933 0.2435 0.2609 0.1838 0.2149
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Table 3: Utilization and Estimated Needs by Income Quantile
Age No.
of
Symptoms
Year Util./Needs Bottom
20%
20-
40%
40-
60%
60-
80%
Top
20%
1998 Utilization .278 .294 .184 .235 .569
1995 Utilization .269 .266 .195 .230 .539
1992 Utilization .248 .266 .175 .218 .505
Classes No 1998 SAH .114 .157 .294 .334 .513
Symptoms .161 .199 .287 .320 .444
Both .110 .161 .296 .335 .507
Classes No 1995 SAH .137 .192 .312 .344 .515
Symptoms .186 .224 .314 .332 .440
Both .135 .192 .319 .342 .507
Classes No 1992 SAH .127 .229 .328 .328 .547
Symptoms .183 .250 .346 .309 .468
Both .127 .227 .345 .316 .541
Classes Yes 1998 Symptoms .191 .210 .276 .300 .423
Both .113 .157 .294 .330 .511
Classes Yes 1995 Symptoms .210 .236 .295 .323 .424
Both .135 .191 .310 .346 .510
Classes Yes 1992 Symptoms .212 .258 .310 .316 .452
Both .126 .228 .321 .332 .545
Dummies No 1998 SAH .247 .268 .174 .218 .505
Symptoms .246 .267 .173 .218 .505
Both .246 .267 .173 .219 .505
Dummies No 1995 SAH .268 .269 .193 .231 .538
Symptoms .267 .268 .193 .231 .537
Both .267 .268 .193 .231 .537
Dummies No 1992 SAH .280 .292 .184 .234 .569
Symptoms .280 .291 .182 .234 .569
Both .280 .291 .182 .234 .569
Dummies Yes 1998 Symptoms .248 .265 .173 .219 .505
Both .248 .265 .173 .219 .505
Dummies Yes 1995 Symptoms .262 .281 .184 .231 .538
Both .262 .281 .185 .231 .538
Dummies Yes 1992 Symptoms .304 .265 .185 .234 .569
Both .304 .265 .184 .234 .569
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Table 4: The Estimated Concentration Index, Horizontal
Inequity and Their Confidence Interval
Age No.
of
Symptoms
Year Needs Def./CI Estimator 95%CI
lower
boubd
95%CI up-
per bound
1998 CI .0007 -.0091 .0107
1995 CI .0075 -.0082 .0233
1992 CI .0064 -.0062 .0191
Classes No 1998 SAH -.0048144 -.0114498 .001821
Symptoms .0783489 .0724745 .0842234
Both -.0008935 -.0069083 .0051213
Classes No 1995 SAH -.0012385 -.0077185 .0052415
Symptoms .0825699 .0769057 .088234
Both .001905 -.0039076 .0077177
Classes No 1992 SAH -.0016404 -.0082949 .005014
Symptoms .0849225 .0792991 .0905459
Both -.0005696 -.0063858 .0052465
Classes Yes 1998 Symptoms .1118019 .1055935 .1180104
Both .0023189 -.0041148 .0087526
Classes Yes 1995 Symptoms .1120658 .1060572 .1180744
Both .0005353 -.005711 .0067816
Classes Yes 1992 Symptoms .1274143 .1214338 .1333948
Both .0024351 -.0038694 .0087396
Dummies No 1998 SAH .0008551 -.0044873 .0061976
Symptoms .0002563 -.0048394 .0053521
Both .0002635 -.0047627 .0052897
Dummies No 1995 SAH .0001678 -.0049554 .005291
Symptoms -.0004148 -.0052664 .0044368
Both -.0004874 -.0052775 .0043028
Dummies No 1992 SAH .0006951 -.004251 .0056413
Symptoms -.0002273 -.0049104 .0044558
Both -.0003296 -.0049545 .0042954
Dummies Yes 1998 Symptoms .0008852 -.004466 .0062364
Both .001191 -.0040259 .0064079
Dummies Yes 1995 Symptoms -.0007807 -.0058842 .0043228
Both -.0000584 -.0050583 .0049416
Dummies Yes 1992 Symptoms -.0001778 -.0051346 .0047791
Both .0002361 -.0046002 .0050724
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Table 5: The Estimated orizontal Inequity and Their
Confidence Interval, cotrolled with Regional Dummies
Age No.
of
Symptoms
Year Needs Def./CI Estimator 95%CI
lower
boubd
95%CI up-
per bound
Classes No 1998 SAH -.0044354 -.0110766 .0022059
Symptoms .0787252 .0728414 .0846091
Both -.00056 -.0065829 .0054629
Classes No 1995 SAH -.0015081 -.0079876 .0049713
Symptoms .0824537 .0767899 .0881175
Both .0017665 -.0040452 .0075781
Classes No 1992 SAH -.0019883 -.0086423 .0046657
Symptoms .0847203 .0790964 .0903441
Both -.0007749 -.0065911 .0050413
Classes Yes 1998 Symptoms .1123355 .1061217 .1185492
Both .002791 -.0036468 .0092287
Classes Yes 1995 Symptoms .1120204 .1060145 .1180264
Both .0004334 -.0058099 .0066767
Classes Yes 1992 Symptoms .1271793 .121197 .1331616
Both .0022197 -.0040851 .0085245
Dummies No 1998 SAH .0015379 -.0038023 .0068781
Symptoms .000738 -.0043597 .0058357
Both .0008135 -.0042142 .0058412
Dummies No 1995 SAH .0003914 -.0047274 .0055102
Symptoms -.0003152 -.0051673 .004537
Both -.0003547 -.0051451 .0044357
Dummies No 1992 SAH .0010876 -.0038597 .006035
Symptoms .0003113 -.0043754 .0049981
Both .0001369 -.004492 .0047658
Dummies Yes 1998 Symptoms .0014243 -.0039275 .0067761
Both .0018136 -.0034037 .0070309
Dummies Yes 1995 Symptoms -.0005587 -.0056617 .0045443
Both .0001573 -.0048427 .0051573
Dummies Yes 1992 Symptoms .0002488 -.0047113 .005209
Both .0005927 -.0042472 .0054325
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Fig.1 Concenration Curve of Utilization  minus Needs in 1992 −:SAH, −−:Symptoms,...:Both
Proportion of Cumulative Distribution of Income
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Fig.2 Concenration Curve of Utilization  minus Needs in 1995 −:SAH, −−:Symptoms,...:Both
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Fig.3 Concenration Curve of Utilization  minus Needs in 1998 −:SAH, −−:Symptoms,...:Both
Proportion of Cumulative Distribution of Income
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